Laser Diffraction Software Supports Analytical QbD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Laser Diffraction Software Supports Analytical QbD


Pharmaceutical Technology
Volume 38, Issue 5, pp. 2

A software upgrade for the Mastersizer 3000 laser diffraction particle size analyzer from Malvern Instruments decreases the analytical workload associated with developing and validating particle sizing methods. New operational features, such as an Optical Property Optimizer (OPO ), simplify the process of method development. The new OPO tool enables the identification of appropriate refractive index and absorption values for the analysis of any given sample. It also allows analysts to research the impact of optical properties on reported particle size, in real time, using an intuitive point-and-click tool. According to the company, this helps exploration of the operating space in which robust measurements are assured, to define the method operable design region for a particle size analysis method.

Malvern Instruments

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here